GlassScriptPhysician profile
Arvind Sabesan
NPI 1023308574
$10,265.07
in general payments reported to CMS, 2019-2025
7 companies · $5,904 in 2025
The $5,904 reported for 2025 was more than what 91% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,050 · 2022: $2,398 · 2023: $79.53 · 2024: $833 · 2025: $5,904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,339 · Education: $2,500 · Food and Beverage: $978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,339.03 |
| Education | $2,500.00 |
| Food and Beverage | $977.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,013.33 | 2021-2025 | |
| Histosonics, INC. | $1,005.70 | 2024-2025 | |
| Ethicon US, LLC | $79.53 | 2023 | Vistaseal, Echelon; Endopath, Harmonic |
| Regeneron Healthcare Solutions, INC. | $78.00 | 2025 | Libtayo |
| Angiodynamics, INC. | $37.50 | 2021-2022 | |
| Bioventus LLC | $32.14 | 2024 | Sonastar |
| Hologic Sales and Service, LLC | $18.87 | 2025 | Coolseal Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arvind Sabesan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.